Top Story
Until Wednesday, Kentucky was following guidance from the U.S. Centers for Disease Control and Prevention.
From
To
AP Wire
At this time, no booster dose is recommended for those that received the Johnson & Johnson COVID-19 vaccine.
The shot will combine Moderna's current COVID-19 vaccine with a new flu vaccine that is still under development.
Wire
Moderna's COVID-19 vaccine could become second to win full approval following Pfizer/BioNTech.
Kentucky reported 4,009 newly confirmed cases on COVID-19 on Friday, along with a positivity rate of 11.83%.
There are at least seven upcoming mobile events beginning Thursday, June 24 where people can go to get a vaccine.
The company hopes to have it rolled out by this fall, according to its CEO Stephane Bancel. Clinical data on a booster shot could come in May.
Indiana is one of 20 universities doing research with about 12,000 college students ages 18 to 26.
Wire
Results indicated a 90% drop in infection risk after participants were fully vaccinated, or in other words, two weeks after they received second jabs developed by Pfizer or Moderna.